Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Privia Health Group (PRVA)

Privia Health adds Lance Berberian to board as director and Audit Committee member

Neutral Impact 2 of 5 leadership Written later

Privia Health Group expanded its board from nine to ten directors and elected Lance Berberian as a Class III director effective July 15, 2025, with a seat on the Audit Committee. The former Labcorp technology chief brings IT, cybersecurity and digital transformation experience to the board, according to the filing.

Key points

  • Board size increased from nine to ten directors; Berberian elected effective July 15, 2025
  • Berberian appointed to the Audit Committee effective July 15, 2025
  • Director pay includes an annual cash retainer and restricted stock units with a grant date fair value of $200,000
  • Berberian served as EVP and Chief Information and Technology Officer at Labcorp from 2014 to October 2024

The filing

CompanyPrivia Health Group (PRVA)
Form8-K, current report
Filed with the SECJul 8, 2025, 9:03 AM ET
Accession number0001759655-25-000080

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:49 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 08, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.